Market Tracker

08/28 6:01pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.17
Delayed Data
As of Aug 28
 +0.26 / +0.69%
Today’s Change
22.04
Today|||52-Week Range
51.99
+20.22%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close37.91
Today’s open37.53
Day’s range37.02 - 38.41
Volume777,372
Average volume (3 months)1,127,985
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-70.79%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book12.34

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.14-0.45%
NBIXNeurocrine Bioscienc...+0.41+0.89%
RAREUltragenyx Pharmaceu...+5.33+4.93%
ICPTIntercept Pharmaceut...-0.39-0.21%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts